Please login to the form below

Not currently logged in
Email:
Password:

Eucomed commits to value-based innovation

Eucomed, the European medical technology body, has launched its five-year strategy, which includes a commitment to value-based innovation

Eucomed, the European medical technology body, has launched its five-year strategy, which includes a commitment to value-based innovation.

The association presented its 'Contract for a Healthy Future' report at the MedTech Forum in Brussels, Belgium, describing the role the medical technology industry must take to ensure healthcare across Europe has a sustainable future.

The strategy includes plans to deliver and demonstrate cost-efficiency and health outcome needs of payers and policymakers.

Guy Lebeau, chairman of Eucomed, said: "The future will demand a different kind of innovative thinking from all stakeholders in our economies.

"We will take the first step and deliver value-based innovations that deliver a demonstrable positive return on investment in healthy life years for citizens."

The strategy also outlines Eucomed's demands to healthcare stakeholders across Europe, requesting that policymakers build better cost models and end silo-based budgeting. Payers are asked to achieve health productivity and efficiency by prioritising value not price.

This supports a separate report published by the Economist Intelligence Unit (EIU) that says the medical technology industry in Europe must support healthcare in the region by collecting, developing and sharing evidence-based cases of technologies that demonstrate the real value in innovation.

Download both reports from Reforming Healthcare in Europe.

12th October 2011

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Dovetail

We’re a specialist health consultancy that supports companies, healthcare professionals and patients to work hand in hand with a common...

Latest intelligence

JulAug cover image
The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...
Virtual Speaker Program: A Customer Story
Learn how we helped our client develop a virtual speaker program and roll out a series of regional peer-to-peer education sessions....